Epstein-Barr virus-encoded dUTPase modulates immune function and induces sickness behavior in mice

Journal of Medical Virology

Volumn 74, Issue 3, 2004, Pages 442-448

  Padgett, David A ^a,b,c   Hotchkiss, Andrew K ^b   Pyter, Leah M ^b   Nelson, Randy J ^b   Yang, Eric ^a,b   Yeh, Peir En ^b   Litsky, Monica ^b   Williams, Marshall ^a,c   Glaser, Ronald ^a,b,c  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

dUTPase; Epstein Barr virus; Interferon gamma; Interleukin 10; Sickness behavior

Indexed keywords

ANTIBODY; DEOXYURIDINE TRIPHOSPHATE PYROPHOSPHATASE; EARLY ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; MITOGENIC AGENT; VIRUS ENZYME; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY MASS; BODY TEMPERATURE; BURKITT LYMPHOMA; CELL DIVISION; CONTROLLED STUDY; CYTOKINE PRODUCTION; EPSTEIN BARR VIRUS; ILLNESS BEHAVIOR; IMMUNE RESPONSE; IN VIVO STUDY; INFECTIOUS MONONUCLEOSIS; LOCOMOTION; LYMPHOCYTE ACTIVATION; MALE; MOUSE; NASOPHARYNX CARCINOMA; NONHUMAN; PATHOPHYSIOLOGY;

ANIMALS; CONCANAVALIN A; EATING; EPSTEIN-BARR VIRUS INFECTIONS; HERPESVIRUS 4, HUMAN; INTERFERON TYPE II; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; MALE; MICE; MOTOR ACTIVITY; PYROPHOSPHATASES; WEIGHT LOSS;

ANIMALIA; HUMAN HERPESVIRUS 4;

EID: 4644291024     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.20196     Document Type: Article

References (38)

1. Armant MA, Fenton MJ. 2002. Toll-like receptors: A family of pattern-recognition receptors in mammals. Genome Biol 3: Reviews 3011.
2. Baer R, Bankier AT, Biggin MD, Deininger PL, Farrell PJ, Gibson TJ, Hatfull G, Hudson GS, Satchwell SC, Sequin C. 1984. DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature 310:207-211.
3. Barton GM, Medzhitov R. 2002. Control of adaptive immune responses by Toll-like receptors. Curr Opin Immunol 14:380-383.
4. Bilbo SD, Drazen DL, Quan N, He L, Nelson RJ. 2002. Short day lengths attenuate the symptoms of infection in Siberian hamsters. Proc R Soc Lond B Biol Sci 269:447-454.
5. Cheng Y-C, Chen JY, Hoffman PJ, Glaser R. 1980a. Studies on the activity of DNase associated with the replication of the Epstein-Barr virus. Virology 100:334-338.
6. Cheng YC, Chen YY, Glaser R, Henle W. 1980b. Frequency and levels of antibodies to Epstein-Barr virus specific DNase are elevated in patients with nasopharyngeal carcinoma. Proc Natl Acad Sci USA 77:6162-6165.
7. Collins CM, Medveczky PG. 2002. Genetic requirements for the episomal maintenance of oncogenic herpesvirus genomes. Adv Cancer Res 84:155-174.
8. Dantzer R. 2001. Cytokine-induced sickness behavior: Mechanisms and implications. Ann NY Acad Sci 933:222-234.
9. Dukers DF, Meij P, Vervoort MB, Vos W, Scheper RJ, Meijer CJ, Bloemena E, Middeldorp JM. 2000. Direct immunosuppressive effects of EBV-encoded latent membrane protein 1. J Immunol 165:663-670.
10. Favre N, Bordmann G, Rudin WJ. 1997. Comparison of cytokine measurements using ELISA, ELISPOT and semi-quantitative RT-PCR. Immunol Meth 204:57-66.
11. Glaser R, Kiecolt-Glaser JK. 1998. Stress-associated immune modulation: Relevance to viral infections and chronic fatigue syndrome. Am J Med 105:35s-42s.
12. Glaser R, Pearson GR, Jones JF, Hillhouse J, Kennedy S, Mao H, Kiecolt-Glaser JK. 1991. Stress-related activation of Epstein-Barr virus. Brain Behav Immun 5:219-232.
13. Glaser R, Zhang H-Y. 1987. The importance of viral markers in the study of Epstein-Barr virus-associated illness. Bull Inst Pasteur 85:189-200.
14. Glaser R, Ogino T, Zimmerman J, Rapp Jr., F. 1973. Thymadine kinase activity in Burkitt lymphoblastoid stomatic cell hybrids after induction of the EBV virus. Proc Soc Exp Biol & Med 142:1059-1062.
15. Goodman SR, Prezyna C, Benz WC. 1978. Two Epstein-Barr virus-associated DNA polymerase activities. J Biol Chem 253:8617-8628.
16. Heine H, Lien E. 2003. Toll-like receptors and their function in innate and adaptive immunity. Int Arch Allergy Immunol 130:180-192.
17. Henle W, Ho JHC, Henle G, Kwan HC. 1973. Antibodies to Epstein-Barr virus-related antigens in nasopharyngeal carcinoma. Comparison of active cases and long term survivors. J Natl Cancer Inst 51:361-369.
18. Henry BE, Glaser R, Hewetson J, O'Collaghan D. 1978. Expression of altered ribonucleotide reductase activity in Epstein-Barr virus-infected cells. Virology 142:326-333.
19. Kluger MJ, Rothenburg BA. 1979. Fever and reduced iron: Their interaction as a host defense response to bacterial infection. Science 203:374-376.
20. Kozak W, Kluger MJ, Tesfaigzi J, Kozak A, Mayfield KP, Wachulec M, Dokladny K. 2000. Molecular mechanisms of fever and endogenous antipyresis. Ann NY Acad Sci 917:121-134.
21. Levin LI, Munger KL, Rubertone MV, Peck CA, Lennette ET, Spiegelman D, Ascherio A. 2003. Multiple sclerosis and Epstein-Barr virus. JAMA 289:1533-1536.
22. Lidin B, Gartland L, Marshall G, Sanchez V, Lamon EW. 1993. Detection of two early gene products of Epstein-Barr virus by fluorescence flow cytometry. Viral Immunol 6:97-107.
23. Liu MY, Chou WH, Nutter L, Hsu MM, Chen JY, Yang CS. 1989. Antibody against Epstein-Barr virus DNA polymerase activity in sera of patients with nasopharyngeal carcinoma. J Med Virol 28:101-105.
24. Maier SF, Watkins LR. 1998. Cytokines for psychologists: Implications of bidirectional immune-to-brain communication for understanding behavior, mood, and cognition. Psychol Rev 105:83-107.
25. Mathes LE, Olsen RG, Hebebrand LC, Hoover EA, Schaller JP, Adams PW, Nichols WS. 1979. Immunosuppressive properties of a virion polypeptide, a 15,000-dalton protein, from feline leukemia virus. Cancer Res 39:950-955.
26. Miller R, Glaser R, Rapp F. 1977. Studies of an Epstein-Barr virus-induced DNA polymerase. Virology 76:494-502.
27. Montkowski A, Landgraf R, Yassouridis A, Holsboer F, Schobitz B. 1997. Central administration of IL-1 reduces anxiety and induces sickness behavior in rats. Pharmacol Biochem Behav 58:329-336.
28. Nair MP, Pottathil R, Heimer EP, Schwartz SA. 1988. Immunoregulatory activities of human immunodeficiency virus (HIV) proteins: Effect of HIV recombinant and synthetic peptides on immunoglobulin synthesis and proliferative responses by normal lymphocytes. Proc Natl Acad Sci USA 85:6498-6502.
29. O'Neill LA. 2002. Signal transduction pathways activated by the IL-1 receptor/toll-like receptor superfamily. Curr Top Microbiol Immunol 270:47-61.
30. Padgett DA, Loria RM, Sheridan JF. 1997. Endocrine regulation of the immune response to influenza A virus infection with a metabolite of dihydroepiandrosterone-androstenediol. J Neuroimmunol 78:203-211.
31. Reedman BM, Klein G. 1973. Cellular localization of an Epstein-Barr Virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines. Int J Cancer 11:599-620.
32. Ruscetti F, Chervenick P. 1975. Regulation of the release of colony-stimulating activity from mitogen-stimulated lymphocytes. J Immunol 114:1513-1517.
33. Sanberg PR, Zoloty SA, Willis R, Ticarich CD, Rhoads K, Nagy RP, Mitchell SG, Laforest AR, Jenks JA, Harkabus LJ, et al. 1987. Digiscan activity: Automated measurement of thigmotactic and stereotypic behavior in rats. Pharmacol Biochem Behav 27(3):569-572.
34. SAS Institute. 2001. SAS version 8.2, under Procedure "mixed" (proc mixed). Cary, NC.
35. Sommer P, Kremmer E, Bier S, Konig S, Zalud P, Zeppezauer M, Jones JF, Mueller-Lantzsch N, Grasser FA. 1996. Cloning and expression of the Epstein-Barr virus-encoded dUTPase: Patients with acute, reactivated or chronic virus infection develop antibodies against the enzyme. J Gen Virol 77:2795-2805.
36. Swiergiel AH, Smagin GN, Johnson LJ, Dunn AJ. 1997. The role of cytokines in the behavioral responses to endotoxin and influenza virus infection in mice: Effects of acute and chronic administration of the interleukin-1-receptor antagonist (IL-1ra). Brain Res 776:96-104.
37. Williams MV, Parris DS. 1987. Characterization of a herpes simplex virus type 2 deoxyuridine triphosphate nucleotidohydrolase and mapping of gene conferring type specificity for the enzyme. Virology 156:282-292.
38. Williams MV, Holliday J, Glaser R. 1985. Induction of a deoxyuridine triphosphate nucleotidohydrolase activity in Epstein-Barr virus-infected cells. Virology 142:326-333.